Citations (47)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Dongxu Wang & Bing He. (2022) Current Perspectives on Nonalcoholic Fatty Liver Disease in Women with Polycystic Ovary Syndrome. Diabetes, Metabolic Syndrome and Obesity 15, pages 1281-1291.
Read now
Read now
A. T. Ali & F. Guidozzi. (2020) Midlife women’s health consequences associated with polycystic ovary syndrome. Climacteric 23:2, pages 116-122.
Read now
Read now
Gislaine Satyko Kogure, Rafael Costa Silva, Fabiene K. Picchi Ramos, Cristiana Libardi Miranda-Furtado, Lucia Alves da Silva Lara, Rui Alberto Ferriani & Rosana Maria dos Reis. (2015) Women with polycystic ovary syndrome have greater muscle strength irrespective of body composition. Gynecological Endocrinology 31:3, pages 237-242.
Read now
Read now
Carlo Cervellati, Gloria Bonaccorsi, Eleonora Cremonini, Arianna Romani, Enrica Fila, Cristina Castaldini, Stefania Ferrazzini, Leo Massari, Monica Squerzanti, Claudia Sticozzi, Carlo Mischiati & Carlo M. Bergamini. (2013) Accumulation of central fat correlates with an adverse oxidative balance in non-obese postmenopausal women. Gynecological Endocrinology 29:12, pages 1063-1066.
Read now
Read now
Articles from other publishers (43)
Nihan Çakır Biçer, Asime Aleyna Ermiş & Dilşat Baş. (2023) The Role of Different Methods in Defining Cardiometabolic Risk and Metabolic Syndrome in Women with Polycystic Ovary Syndrome. Life 13:10, pages 1959.
Crossref
Crossref
Justyna Jurczewska, Joanna Ostrowska, Magdalena Chełchowska, Mariusz Panczyk, Ewa Rudnicka, Marek Kucharski, Roman Smolarczyk & Dorota Szostak-Węgierek. (2023) Abdominal Obesity in Women with Polycystic Ovary Syndrome and Its Relationship with Diet, Physical Activity and Insulin Resistance: A Pilot Study. Nutrients 15:16, pages 3652.
Crossref
Crossref
Dandan Sun, Yupeng Wu, Mingyan Ding & Fang Zhu. (2022) Comprehensive Meta-Analysis of Functional and Structural Markers of Subclinical Atherosclerosis in Women with Polycystic Ovary Syndrome. Angiology 73:7, pages 622-634.
Crossref
Crossref
Chantal Anifa Amisi. (2022) Markers of insulin resistance in Polycystic ovary syndrome women: An update. World Journal of Diabetes 13:3, pages 129-149.
Crossref
Crossref
Ya.Z. Zaidieva & V.D. Kazantseva. (2022) Polycystic ovary syndrome in middle-aged women: associated diseases. Rossiiskii vestnik akushera-ginekologa 22:1, pages 45.
Crossref
Crossref
Hiya Islam, Jaasia Masud, Yushe Nazrul Islam & Fahim Kabir Monjurul Haque. (2022) An update on polycystic ovary syndrome: A review of the current state of knowledge in diagnosis, genetic etiology, and emerging treatment options. Women's Health 18, pages 174550572211179.
Crossref
Crossref
Shiqin Zhu, Zeyan Li, Cuiping Hu, Fengxuan Sun, Chunling Wang, Haitao Yuan & Yan Li. (2021) Imaging-Based Body Fat Distribution in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis. Frontiers in Endocrinology 12.
Crossref
Crossref
Alexandra L.P. Dietz de Loos, Geranne Jiskoot, Reinier Timman, Annemerle Beerthuizen, Jan J.V. Busschbach & Joop S.E. Laven. (2021) Improvements in PCOS characteristics and phenotype severity during a randomized controlled lifestyle intervention. Reproductive BioMedicine Online 43:2, pages 298-309.
Crossref
Crossref
Krystallenia I Alexandraki, Eleni A Kandaraki, Kalliopi-Anna Poulia, Christina Piperi, Eirini Papadimitriou & Theodoros G Papaioannou. (2021) Assessment of Early Markers of Cardiovascular Risk in Polycystic Ovary Syndrome. touchREVIEWS in Endocrinology 17:1, pages 37.
Crossref
Crossref
Krystallenia I Alexandraki, Eleni A Kandaraki, Kalliopi-Anna Poulia, Christina Piperi, Eirini Papadimitriou & Theodoros G Papaioannou. (2021) Assessment of Early Markers of Cardiovascular Risk in Polycystic Ovary Syndrome. European Endocrinology 1:1, pages 37.
Crossref
Crossref
Murat Gözüküçük, Aslı Yarcı Gürsoy, Emre Destegül, Salih Taşkın & Hakan Şatıroğlu. (2020) Adiponectin and leptin levels in normal weight women with polycystic ovary syndrome. Hormone Molecular Biology and Clinical Investigation 41:4.
Crossref
Crossref
V Wekker, L van Dammen, A Koning, K Y Heida, R C Painter, J Limpens, J S E Laven, J E Roeters van Lennep, T J Roseboom & A Hoek. (2020) Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis. Human Reproduction Update 26:6, pages 942-960.
Crossref
Crossref
Barnali Ray BasuDr.Dr., Sanchari ChakrabartySudip Kumar SahaDr.Dr. & Nilansu DasDr.Dr.. (2020) EVALUATION OF ASSOCIATION OF ANTHROPOMETRIC INDICES WITH STRESS RESPONSE IN PCOS POPULATION. INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH, pages 1-5.
Crossref
Crossref
Gültekin ADANAS & Hilal Gülsm TURAN ÖZSOY. (2020) The relationship between prolactin and adipose tissue and metabolic parameters in patients with polycystic ovary syndrome. The European Research Journal 6:5, pages 517-526.
Crossref
Crossref
Rhea Jabbour, Johannes Ott, Wolfgang Eppel & Peter Frigo. (2020) Carotid intima-media thickness in polycystic ovary syndrome and its association with hormone and lipid profiles. PLOS ONE 15:4, pages e0232299.
Crossref
Crossref
Maria Mitkova Orbetzova. 2020. Polycystic Ovarian Syndrome. Polycystic Ovarian Syndrome.
Elham Hosseini Marnani, Akram Ghadiri-Anari, Nahid Ramezani-Jolfaie, Mohammad Mohammadi, Nooshin abdollahi, Seyedeh Mahdieh Namayandeh, Hassan Mozaffari-Khosravi, Amin Salehi-Abargouei & Azadeh Nadjarzadeh. (2020) Effect of fennel supplementation along with high-protein, low-carbohydrate weight-loss diet on insulin resistance and percentage of fat and muscle mass in overweight/obese women with polycystic ovary syndrome. Journal of Functional Foods 67, pages 103848.
Crossref
Crossref
Laura E. McBreairty, Philip D. Chilibeck, Julianne J. Gordon, Donna R. Chizen & Gordon A. Zello. (2019) Polycystic ovary syndrome is a risk factor for sarcopenic obesity: a case control study. BMC Endocrine Disorders 19:1.
Crossref
Crossref
Eleni Armeni & Irene Lambrinoudaki. (2019) Cardiovascular Risk in Postmenopausal Women with Polycystic Ovary Syndrome. Current Vascular Pharmacology 17:6, pages 579-590.
Crossref
Crossref
Małgorzata Jacewicz‐Święcka & Irina Kowalska. (2018) Polycystic ovary syndrome and the risk of cardiometabolic complications in longitudinal studies. Diabetes/Metabolism Research and Reviews 34:8.
Crossref
Crossref
Liangshan Mu, Yue Zhao, Rong Li, Yuchen Lai & Jie Qiao. (2018) Metabolic characteristics of normal weight central obesity phenotype polycystic ovary syndrome women: a large-scale national epidemiological survey. Reproductive BioMedicine Online 37:4, pages 498-504.
Crossref
Crossref
André Tchernof, Dannick Brochu, Ina Maltais‐Payette, Mohamed Fouad Mansour, Geneviève B. Marchand, Anne‐Marie Carreau & Jordanna Kapeluto. 2011. Comprehensive Physiology. Comprehensive Physiology
1253
1290
.
Katica Bajuk Studen & Marija Pfeifer. (2018) Cardiometabolic risk in polycystic ovary syndrome. Endocrine Connections 7:7, pages R238-R251.
Crossref
Crossref
Debarchan Jena, ArunKumar Choudhury, Swayamsidha Mangaraj, Mamata Singh, BinoyKumar Mohanty & AnojKumar Baliarsinha. (2018) Study of visceral and subcutaneous abdominal fat thickness and its correlation with cardiometabolic risk factors and hormonal parameters in polycystic ovary syndrome. Indian Journal of Endocrinology and Metabolism 22:3, pages 321.
Crossref
Crossref
Åsa Nybacka, Per M. Hellström & Angelica L. Hirschberg. (2017) Increased fibre and reduced trans fatty acid intake are primary predictors of metabolic improvement in overweight polycystic ovary syndrome—Substudy of randomized trial between diet, exercise and diet plus exercise for weight control. Clinical Endocrinology 87:6, pages 680-688.
Crossref
Crossref
Priyadarshini Tripathy, Asutosh Sahu, Mahija Sahu & Attila Nagy. (2017) Ultrasonographic evaluation of intra-abdominal fat distribution and study of its influence on subclinical atherosclerosis in women with polycystic ovarian syndrome. European Journal of Obstetrics & Gynecology and Reproductive Biology 217, pages 18-22.
Crossref
Crossref
Yang Xu. (2017) Selection of Appropriate Tools for Evaluating Obesity in Polycystic Ovary Syndrome Patients. EMJ Reproductive Health, pages 48-52.
Crossref
Crossref
Maria A. Sortino, Salvatore Salomone, Michele O. Carruba & Filippo Drago. (2017) Polycystic Ovary Syndrome: Insights into the Therapeutic Approach with Inositols. Frontiers in Pharmacology 8.
Crossref
Crossref
F. Orio, G. Muscogiuri, F. Giallauria, S. Savastano, P. Bottiglieri, D. Tafuri, P. Predotti, G. Colarieti, A. Colao & S. Palomba. (2016)
Oral contraceptives
versus
physical exercise on cardiovascular and metabolic risk factors in women with polycystic ovary syndrome: a randomized controlled trial
. Clinical Endocrinology 85:5, pages 764-771.
Crossref
Crossref
Samer El Hayek, Lynn Bitar, Layal H. Hamdar, Fadi G. Mirza & Georges Daoud. (2016) Poly Cystic Ovarian Syndrome: An Updated Overview. Frontiers in Physiology 7.
Crossref
Crossref
Ya-jie Zhang, Hua Jin, Zhen-li Qin, Jin-long Ma, Han Zhao, Ling Zhang & Zi-jiang Chen. (2016) Predictors of Gestational Diabetes Mellitus in Chinese Women with Polycystic Ovary Syndrome: A Cross-Sectional Study. Gynecologic and Obstetric Investigation 81:3, pages 220-224.
Crossref
Crossref
Dilek Arpaci, Aysel Gurkan Tocoglu, Sabiye Yilmaz, Hasan Ergenc, Ali Tamer, Nurgul Keser & Huseyin Gunduz. (2015) The relationship between epicardial fat tissue thickness and visceral adipose tissue in lean patients with polycystic ovary syndrome. Journal of Ovarian Research 8:1.
Crossref
Crossref
Serap Baydur. Sahin, Tugba. Durakoglugil, Teslime. Ayaz, Osman Zikrullah. Sahin, Emre Durakoglugil, Fatih Sumer, Ezgi Aktas & Nese Alyildiz. (2015) Evaluation of Para- and Perirenal Fat Thickness and its Association with Metabolic Disorders in Polycystic Ovary Syndrome. Endocrine Practice 21:8, pages 878-886.
Crossref
Crossref
Nahid Nasiri, Ashraf Moini, Poopak Eftekhari-Yazdi, Leila Karimian, Reza Salman-Yazdi, Zahra Zolfaghari & Arezoo Arabipoor. (2015) Abdominal obesity can induce both systemic and follicular fluid oxidative stress independent from polycystic ovary syndrome. European Journal of Obstetrics & Gynecology and Reproductive Biology 184, pages 112-116.
Crossref
Crossref
Chan-Hee Jung, Bo-Yeon Kim, Kyu-Jin Kim, Sang-Hee Jung, Chul-Hee Kim, Sung-Koo Kang & Ji-Oh Mok. (2014) Contribution of subcutaneous abdominal fat on ultrasonography to carotid atherosclerosis in patients with type 2 diabetes mellitus. Cardiovascular Diabetology 13:1.
Crossref
Crossref
Amy M. Goss, Paula C. Chandler-Laney, Fernando Ovalle, Laura Lee Goree, Ricardo Azziz, Renee A. Desmond, G. Wright Bates & Barbara A. Gower. (2014) Effects of a eucaloric reduced-carbohydrate diet on body composition and fat distribution in women with PCOS. Metabolism 63:10, pages 1257-1264.
Crossref
Crossref
Fahimeh Ramezani Tehrani, Sonia Minooee & Fereidoun Azizi. (2014) Comparison of various adiposity indexes in women with polycystic ovary syndrome and normo-ovulatory non-hirsute women: a population-based study. European Journal of Endocrinology 171:2, pages 199-207.
Crossref
Crossref
Susana Borruel, Elena Fernández-Durán, Macarena Alpañés, David Martí, Francisco Álvarez-Blasco, Manuel Luque-Ramírez & Héctor F. Escobar-Morreale. (2013) Global Adiposity and Thickness of Intraperitoneal and Mesenteric Adipose Tissue Depots Are Increased in Women With Polycystic Ovary Syndrome (PCOS). The Journal of Clinical Endocrinology & Metabolism 98:3, pages 1254-1263.
Crossref
Crossref
Rafael Montes-Nieto, María Insenser, M. Ángeles Martínez-García & Héctor F. Escobar-Morreale. (2013) A Nontargeted Proteomic Study of the Influence of Androgen Excess on Human Visceral and Subcutaneous Adipose Tissue Proteomes. The Journal of Clinical Endocrinology & Metabolism 98:3, pages E576-E585.
Crossref
Crossref
S. S. Lim, R. J. Norman, M. J. Davies & L. J. Moran. (2012) The effect of obesity on polycystic ovary syndrome: a systematic review and meta‐analysis. Obesity Reviews 14:2, pages 95-109.
Crossref
Crossref
Grace Huang & Andrea Coviello. (2012) Clinical update on screening, diagnosis and management of metabolic disorders and cardiovascular risk factors associated with polycystic ovary syndrome. Current Opinion in Endocrinology, Diabetes & Obesity 19:6, pages 512-519.
Crossref
Crossref
. (2012) Current World Literature. Current Opinion in Obstetrics & Gynecology 24:6, pages 470-478.
Crossref
Crossref
Joseph S. Marino, Jeffrey Iler, Abigail R. Dowling, Streamson Chua, Jens C. Bruning, Roberto Coppari & Jennifer W. Hill. (2012) Adipocyte Dysfunction in a Mouse Model of Polycystic Ovary Syndrome (PCOS): Evidence of Adipocyte Hypertrophy and Tissue-Specific Inflammation. PLoS ONE 7:10, pages e48643.
Crossref
Crossref